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Disclosure of complementary 
medicine use to medical providers: a 
systematic review and meta-analysis
H. Foley  1, A. steel  1, H. Cramer1,2, J. Wardle1 & J. Adams1
Concomitant complementary medicine (CM) and conventional medicine use is frequent and carries 
potential risks. Yet, CM users frequently neglect to disclose CM use to medical providers. our systematic 
review examines rates of and reasons for CM use disclosure to medical providers. observational 
studies published 2003–2016 were searched (AMED, CINAHL, MEDLINE, PsycINFO). Eighty-six papers 
reporting disclosure rates and/or reasons for disclosure/non-disclosure of CM use to medical providers 
were reviewed. Fourteen were selected for meta-analysis of disclosure rates of biologically-based CM. 
Overall disclosure rates varied (7–80%). Meta-analysis revealed a 33% disclosure rate (95%CI: 24% 
to 43%) for biologically-based CM. Reasons for non-disclosure included lack of inquiry from medical 
providers, fear of provider disapproval, perception of disclosure as unimportant, belief providers lacked 
CM knowledge, lacking time, and belief CM was safe. Reasons for disclosure included inquiry from 
medical providers, belief providers would support CM use, belief disclosure was important for safety, 
and belief providers would give advice about CM. Disclosure appears to be influenced by the nature 
of patient-provider communication. However, inconsistent definitions of CM and lack of a standard 
measure for disclosure created substantial heterogeneity between studies. Disclosure of CM use to 
medical providers must be encouraged for safe, effective patient care.
Health care seeking invariably involves choices regarding the use of what can often be many competing health 
care services, treatments and providers from both within and beyond the public health care system. This level of 
individual choice in health seeking is increasingly recognised with person-centred care being given predilection 
as a favourable model of care provision in public health1,2, situating individuals as active participants at the centre 
of their health management. Patient autonomy and preference are important features of person-centred care2 to 
be considered by medical providers alongside safety and treatment outcomes in their patient management.
Amidst this context, complementary medicine (CM) - a broad, varied field of health care practices and prod-
ucts customarily excluded from conventional medical practice and dominant health care systems3 – is often the 
focus of relatively hidden patient health seeking yet is making its presence felt in primary care, chronic disease 
management and other areas4. Despite appreciable gaps in evidence of effectiveness5, CM use remains prevalent 
amongst the general population6. While there is controversy amongst medical providers around the role and 
value of CM7, the vast majority of CM use is concurrent to conventional medicine8 with CM users visiting a GP 
more frequently than non-CM users9.
Serious adverse effects and harm from CM appear relatively rare but substantial associated direct and indirect 
risks remain10,11, particularly regarding ingestive biologically-based CM (such as herbal medicines or supple-
ments)12–14, which may be obtained from unreliable sources, self-prescribed or consumed without professional 
supervision11,15. Exacerbating such risks is an absence of both awareness of concurrent CM and conventional 
medicine use, and of procedures ensuring appropriate oversight of concurrent use11. Furthermore, patients often 
approach CM as inherently safe and may not perceive a need to communicate their CM use to medical provid-
ers16,17. Addressing the risks associated with concurrent use is the responsibility of both patients and their medical 
providers18, and arguably essential for general practitioners in their capacity as primary care gatekeepers19.
A previous review of the literature pertaining to CM use disclosure to medical providers published in 2004 
identified twelve papers published between 1997–2002 reporting a CM disclosure rate of 23–90% alongside key 
factors - patient concern about possible negative response from their medical provider, patient perception that 
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the medical provider was not sufficiently knowledgeable in CM and therefore unable to contribute useful infor-
mation, and the absence of medical provider inquiry about the patient’s CM use – fuelling non-disclosure20. 
Disclosure has been increasingly identified as a central challenge facing patient management amidst concurrent 
use over the last 13 years21,22 but no systematic review or meta-analysis has been conducted on this topic over this 
recent period.
In direct response, this paper provides an update to the previous review, assessing research findings regard-
ing CM use disclosure to medical providers since 2003. Our review employs a qualitative synthesis to explore 
disclosure rates, patient attitudes to disclosure, reasons for disclosing and not disclosing, and the role of 
patient-provider communication in disclosure. In addition, to gain further insight into the extent of this impor-
tant health services issue across settings, we undertook a meta-analysis of disclosure rates among patients using 
ingestive biologically-based CM.
Methods
A review protocol was developed in accordance with the PRISMA-P (Preferred Reporting Items for Systematic 
review and Meta-Analysis Protocols) 2015 checklist23 and MOOSE (Meta-analysis of Observational Studies in 
Epidemiology) guidelines (see Supplementary Methods S1)24. We developed the protocol for the systematic 
review before initiating the literature search. The protocol was not registered on a systematic review protocol 
database. The strategy for the meta-analysis was developed after all articles had been selected for the systematic 
review based upon the trend we observed in the rates of disclosure among individuals using biologically-based 
CM products. Prior to initiating the meta-analysis the protocol was modified to define the statistical methods we 
would employ for the quantitative synthesis. The final manuscript was prepared in accordance with AMSTAR 
guidelines25 where appropriate with respect to the observational nature of the review aim.
Review aim. This review aims to describe the prevalence and characteristics of disclosure of CM use to med-
ical providers.
search strategy. The search strategy was informed by the review published by Robinson & McGrail20. A 
search was conducted on 13–14 February 2017 on the EBSCOhost platform of the following databases: AMED, 
CINAHL, MEDLINE, and PsycINFO. Three search strings were combined to identify studies which assessed 
the use of CM, patient-provider communication, and conventional medicine clinical settings. CM search terms 
were chosen on the basis of CM modalities identified as common in use among the general population in recent 
literature26. Truncation symbols were applied where appropriate to capture related terms. The full search string 
was as follows: S1 (complementary medicine OR complementary therap* OR alternative medicine OR alternative 
therap* OR natural medicine OR natural therap* OR acupunctur* OR aromatherap* OR ayurved* OR chiropract* 
OR herbal* OR phytotherap* OR homeopath* OR hypnosis OR hypnotherap* OR massage OR naturopath* OR 
nutrition* OR diet therap* OR vitamin therap* OR supplement OR osteopath* OR reflexology* OR traditional 
Chinese medicine OR yoga) AND S2 (disclos* OR communicat* OR patient use OR reasons for use OR discuss*) 
AND S3 (medical practi* OR general practi* OR health care provider OR primary care provider OR physician). The 
full search strategy is outlined in Table 1.
In order to provide an update on the review by Robinson & McGrail20, a date range of January 2003 to 
December 2016 was set. The reference and bibliographic lists of all studies included in the review were searched 
to minimise the likelihood of missed citations. In addition, any systematic reviews identified during the literature 
search which presented data on topics related to the primary research aim were also searched manually. The 
authors contributed their own content expertise in clinical practice, health services research and primary care to 
ensure important known articles were not overlooked.
selection criteria. Our review included cross-sectional data from observational studies as this research 
design was deemed the most appropriate for determining prevalence of health behaviours, determinants and 
outcomes27. All observational study designs constituting original, peer-reviewed research were considered for 
the qualitative synthesis if they reported on rates of, or reasons for, disclosure/non-disclosure of CM use to con-
ventional medicine providers by a broad range of members from the general population. CM use was defined as 
the use of any practice or product falling outside of those considered part of conventional medicine28, whether 
administered as self-treatment or by a CM practitioner. We excluded experimental study designs, which may 
have impacted on natural communication patterns between patients and providers, alongside studies assessing 
specific populations which could not reasonably be considered to represent a broad range of individuals (e.g. 
disease-specific populations). Studies were not excluded on the basis of language.
During selection of studies for meta-analysis, additional criteria were applied with respect to homogene-
ity, in order to ensure the central estimate of disclosure frequency would provide external validity. This addi-
tional criteria required that participants were adults, the study reported a true and well-defined rate of disclosure 
occurring within the previous twelve months, and involved participants who used biologically-based CM (herbs/
plant-based medicines, vitamins, minerals and other oral supplements). Of those papers reporting studies sharing 
a common data source (e.g. if multiple papers reported on data from the same survey study), we included only 
one of those publications in order not to artificially inflate our sample size. In such cases, the risk of bias was eval-
uated for all such publications and only included that publication deemed to have the lowest risk of bias.
study selection. Citations were exported into EndNote X8 (Clarivate Analytics 2017) reference manage-
ment software for assessment. Following removal of duplicates, the initial citations were screened against inclu-
sion/exclusion criteria by title and abstract. Review and commentary articles were set aside for a manual search 
of their included studies. Remaining citations were screened by full-text perusal and those found to adhere to all 
selection criteria were selected for review. The reference lists of the selected studies were manually searched for 
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additional articles. Full review of all eligible citations was conducted by the lead author (HF). A selected sample 
of eligible studies (10%) were reviewed at each stage of screening by a second reviewer (AS), as were any studies 
under question, and discrepancies were addressed through discussion until consensus was reached. The justifica-
tion for excluding articles following screening the full text was recorded.
Data extraction and risk of bias assessment. Papers selected for review were re-read thoroughly 
with data extracted into pre-prepared tables outlining study characteristics, outcomes of interest (disclosure/
non-disclosure rates and reasons) and parameters of those outcomes (CM type disclosed, how disclosure was 
defined). Further to this, papers were read in full-text once more to identify other notable findings relating to dis-
closure, which were categorised and tabulated heuristically. The template for data extraction was drafted during 
the pre-review protocol development phase with agreement from all authors. Data extraction was conducted by 
one reviewer (HF) with a selected sample (10% alongside any data under question) checked by another reviewer 
(AS). Any discrepancies were addressed through discussion until consensus was reached.
The resulting tables were examined to identify studies meeting the criteria for meta-analysis. These identified 
studies were subjected to risk of bias assessment using Hoy et al.’s tool for prevalence studies, which assesses ten 
items across four domains (sample selection, non-response bias, measurement bias, analysis bias) alongside a 
summary score29. Studies identified as high risk of bias were excluded from the final selection for meta-analysis. 
Risk of bias was considered high if four or more items were not adequately addressed, if the first three items 
indicated an unacceptable level of sampling bias, or if item ten was not adequately addressed as this item affected 
calculation of disclosure rates.
Data synthesis and statistical analysis. Due to the expected heterogeneity of each study’s parameters of 
disclosure, no average disclosure rate was calculated for the full review; instead a meta-analysis was conducted on 
those studies demonstrating sufficient homogeneity in study design and a low risk of bias. The principal summary 
measure used for meta-analysis was disclosure rate of CM use to medical providers. Meta-analysis was conducted 
using events (number of disclosers) and subset of sample size (number of CM users) to determine event rates 
of disclosure. Where studies reported disclosure rates only as percentages, events were calculated using figures 
for the number of participants who responded to the disclosure question. Where these figures were unavailable, 
the study was considered to fail to address item 10 on the risk of bias assessment tool and was excluded from 
meta-analysis.
Statistical heterogeneity between studies was explored using I2 and chi-square statistics. I2 values greater than 
25%, greater than 50%, and greater than 75% indicate moderate, substantial, and considerable heterogeneity, 
respectively30. Due to the relatively low power of this test, a P value of 0.10 or less from the chi-square test was 
regarded to indicate significant heterogeneity30. Analysis was completed using Comprehensive Meta-Analysis V3 
software (Biostat Inc. 2017).
Results
From an initial 5,071 non-duplicate citations, eighty-six studies were selected for review. The reasons for exclu-
sion at full-text screening are provided in Table 2.
Risk of bias assessment. Twenty studies met the initial inclusion criteria for meta-analysis and were 
subjected to assessment of reporting quality and risk of bias using Hoy et al.’s tool for prevalence studies29. 
Collectively, studies performed poorly across most domains relating to external validity, either due to poor meth-
odological conduct or inadequate reporting on methods relating to target population (item 1), random selection 
(item 3) and response bias (item 4). However, sampling frame representation was well conducted and reported 
(item 2). Domains relating to internal validity were addressed well, with the exception of instrument validity 
(item 7).
Of the twenty studies, four were found to exhibit a high risk of bias due to poorly defined parameters for 
disclosure rate definition or analysis31–34 and were consequently excluded from meta-analysis. The remaining 
sixty-six studies which did not meet the initial inclusion criteria for meta-analysis represented a heterogeneous 
range of study designs in which disclosure was not reported as a primary outcome, but as a secondary outcome 
or qualitative finding, and thus the resulting data underwent narrative synthesis without risk of bias appraisal. 
Table 3 displays full details of risk of bias assessment.
Protocol title Disclosure of complementary medicine use to medical providers: An update and systematic review
Date Jan 2003–Dec 2016
Database
Platform Search String Expanders
AMED
EBSCOhost
S1 (complementary medicine OR complementary therap* OR alternative medicine 
OR alternative therap* OR natural medicine OR natural therap* OR acupunctur* 
OR aromatherap* OR ayurved* OR chiropract* OR herbal* OR phytotherap* OR 
homeopath* OR hypnosis OR hypnotherap* OR massage OR naturopath* OR nutrition* 
OR diet therap* OR vitamin therapy OR supplement OR osteopath* OR reflexolog* OR 
traditional Chinese medicine OR yoga)
AND S2 (disclos* OR communicat* OR patient use OR reasons for use OR discuss*)
AND S3 (medical practi* OR general practi* OR health care provider OR primary care 
provider OR physician)









Table 1. Search strategy.
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study characteristics. Of the eighty-six studies reviewed, seventy-nine provided quantitative data31–33,35–110, 
three qualitative data111–113, and four mixed-method data34,114–116 relevant to CM disclosure rates and/or rea-
sons for disclosure/non-disclosure (selection process summarised in Fig. 1). Nine studies were excluded 
following review of the full text. A vast majority of the selected studies (n = 83) used a cross-sectional sur-
vey design31,32,34–110,114–116, two employed a multistage qualitative approach111,112, and one an ethnographic 
interview design113. While the final selection of research spanned twenty countries, just under half of the 
studies (n = 40) were conducted in the United States (US)31–35,37,40,41,43–54,56,57,60,76,79,80,87–91,94,100,101,105,107,108,112–
114. Settings were diverse with data collection occurring primarily in general practice or hospital 
clinics34–38,41,43,55,58,61–64,66,68,69,74,76–79,81,82,86,87,92,97,98,101,103,106,107,109,111,112,114–116, face-to-face in participants’ house-
holds33,39,46–50,52–54,67,70,72,84,85,88–91,93,94,100,102,104, or by telephone and/or mail31,40,45,51,56,57,59,65,73,75,95,96,108,110. Less 
common settings included CM clinics34,42,68, retail outlets60,71,99,105, community meal sites44,113, seminars78,80, and 
online platforms32,83.
While some samples consisted entirely of CM users45,50,51,54,83,89,98, most involved a subset of CM users 
within a larger sample. Full samples ranged from 35 to 34,525 with an average of 4,144. Amongst those studies 
reporting figures for the subset of CM users, samples ranged from 28 to 16,784 with an average of 1,268 and 
a total of 101,417. Participants were predominantly adults with a small number of studies focussed on older 
adults44,57,65,94,95,105,110,113,114, children45,58,63,68,73,97,103,106,115,116, adolescents41,97, or all age groups61,99,112. More than 
half of the studies included users of various types of CM (n = 45)31,35,36,38,41–43,50,51,54,57–59,61–63,65,66,68,72,73,75,76,80–
82,85,88,89,96,97,102–113,115,116, while others were limited to users of specific types of CM such as herbs and/or sup-
plements32–34,37,44–47,52,53,55,56,60,64,67,69–71,74,77–79,83,86,87,92–95,98–101,109,114, yoga48,91, tai chi49,90, mind-body medicine40, 
practitioner-provided CM39, or local traditional medicine84.
A l m o s t  h a l f  o f  t h e  s e l e c t e d  s tu d i e s  ( n  =  4 0 )  u s e d  a  c onv e n i e n c e  s a mp l i n g  m e t
hod32,34–37,41–44,55,58,60–64,66,68,69,74,76–82,86,87,92,97,101,103,106,107,109,111,114–116. However, twenty-two studies used a nationally 
representative sample31,39,40,46–54,59,73,85,89–91,94,96,100,110, while others applied some method of probability randomisa-
tion38,56,65,75,84,88,99, stratification33,45,57,67,70,72,93,108, weighting71,104,113, or purposiveness95,98,102,105,112 during sampling. 
Table 4 provides full details of the study characteristics identified from the reviewed literature.
Following risk of bias assessment, sixteen studies were considered suitable for meta-analysis of CM disclosure 
rates. Two were excluded from analysis46,52 on the basis that they used data from an earlier version of the same 
national survey as reported in another included manuscript54. Studies selected for meta-analysis represented 
a wide geographical spread including North America35,54,87, Central America88, Continental Europe69,77,82, the 
United Kingdom39, the Middle East38,67,85, West Africa84, and Asia62,81. Sample sizes included in the meta-analysis 
ranged from 35 to 7,493 with an average of 840 and a total of 11,754 CM users. Papers excluded due to a high risk 
of reporting bias represented an additional 3,222 CM users.
prevalence and parameters of disclosure. Rates of disclosure varied substantially across studies, 
ranging from 7%114 to 80%40. Studies including biologically-based CM fell within a range of 7%114 to 77%44, 
while the highest rate of disclosure (80%) was reported by researchers assessing the use of mind-body medi-
cine exclusively40. Parameters used for defining and measuring disclosure also varied, with the most common 
parameters outlined as participant disclosure of their use of CM within the last twelve months to a medical 
provider (n = 30)31–33,36,38,40,45–50,52,54,57,62,65,67,68,70,71,73,81,82,84,85,87,88,95,100,115,116. Others studies examined participants’ 
disclosure to a medical provider of their current CM use35,74,77–79,83,98,109,111, use within the last month34,53,69,86, use 
within the last 24 months50,51, had always/usually/sometimes/never disclosed39,59,60,66,72,110, had ever discussed 
their CM use with a conventional provider37,43,64,75,76, had partially or fully disclosed their CM use56,114, had dis-
closed when asked41, had discussed before use92, reported rates of disclosure per episode of use89, or how the 
patient felt about disclosing80,112. A number of papers did not explicitly define their parameters for measuring 
disclosure42,44,55,58,61,63,90,91,93,94,96,97,99,101–108,113.
First Author Year Title Reason for Exclusion
Anbari133 2015 Evaluation of Trends in the Use of Complementary and Alternative Medicine in Health Centers in Khorramabad (West of Iran) Did not report on disclosure of CM use
Avogo134 2008 The effects of health status on the utilization of complementary and alternative medicine Did not report on disclosure of CM use
Ben-Arye131 2014 Asking patients the right questions about herbal and dietary supplements: Cross cultural perspectives
Experimental study, used intervention to 
deliberately increase disclosure rates
Desai135 2015 Health care use amongst online buyers of medications and vitamins Did not report on disclosure of CM use
Emmerton136 2012 Consumers’ experiences and values in conventional and alternative medicine paradigms: a problem detection study (PDS) Did not report on disclosure of CM use
Featherstone137 2003
Characteristics associated with reported CAM use in patients 
attending six GP practices in the Tayside and Grampian regions of 
Scotland: a survey
Did not report on disclosure of CM use
Harnack138 2003 Results of a population-based survey of adults’ attitudes and beliefs about herbal products Did not report on disclosure of CM use
Hunt139 2010 Complementary and alternative medicine use in England: results from a national survey Did not report on disclosure of CM use
Zhang140 2008 Complementary and alternative medicine use among primary care patients in west Texas Did not report on disclosure of CM use
Table 2. Studies excluded at full text appraisal with reasons for exclusion.
www.nature.com/scientificreports/
5Scientific RepoRts |          (2019) 9:1573  | https://doi.org/10.1038/s41598-018-38279-8
The outcomes of the meta-analysis of the rate of disclosure of CM use by individuals using biologically-based 
CM is presented in Fig. 2. The measure of central tendency provided an overall disclosure rate of 33% (95% CI 
24·1% to 42·8%, I2 = 98·6%). Between the fourteen included studies, the lowest reported disclosure rate was 12% 
and the highest was 59%. Heterogeneity was assessed across the fourteen samples (Q-value 904.955, p < 0.001, 
I2 = 98.563). Although homogeneity was affected by the substantially larger sample size in Jou et al.’s 2016 study54, 
the paper was not excluded as it used a strong, internationally recognised dataset with very low risk of bias. The 
employment of a random effects model accounted for the impact of this study on homogeneity and its inclusion 
was not found to impact significantly on the measure of consistency within this model.
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Djuv 201377 N Y N N Y Y N Y Y Y Moderate
Faith 201531 Y Y Y Y Y Y Y N Y N High
Gyasi 201584 N Y Y N Y Y Y Y Y Y Low
Herron 200335 N Y N N Y Y N Y Y Y Moderate
Hori 200862 N Y N Y Y Y N Y Y Y Low
Hsu 201687 N Y N N Y Y N Y Y Y Moderate
Jou 201654 Y Y Y Y Y Y Y Y Y Y Low
Kennedy 200546 Y Y Y Y Y Y Y Y Y Y Low
Wu 201152 Y Y Y Y Y Y Y Y Y Y Low
McCrea 201132 N N N N Y N N Y Y Y High
Mileva-Peceva 201169 N Y Y N Y Y N Y Y Y Moderate
Naja 201585 Y Y Y N Y Y N Y Y Y Moderate
Nur 201067 N Y Y Y Y Y N Y Y Y Low
Rivera 200733 N Y Y N Y Y N Y Y N High
Shumer 201481 N Y N Y Y N Y Y Y Y Moderate
Tan 200438 N N Y N Y Y N Y Y Y Moderate
Tarn 201534 N Y N N Y Y N Y Y N High
Thomas 200439 Y Y Y N Y Y N Y Y Y Low
Torres-Zeno 201688 N Y Y N Y Y Y Y Y Y Low
Vitale 201482 N Y N N Y Y N Y Y Y Moderate
Table 3. Risk of bias assessment for meta-analysis selection (selected papers in bold). N = criterion not 
adequately met; Y = criterion adequately met.
Figure 1. Literature search and study selection flow chart. Prisma flowchart outlining process of literature 
search and selection of articles for review.
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Reasons for non-disclosure and disclosure. Twenty-five studies reported participant rea-
sons for non-disclosure36,37,42,54–57,59,67,76–79,83–85,90,92,98,105,107,110–113, and four reported reasons for dis-
closure of CM use to medical providers56,111–113. The most commonly cited reasons patients gave for 
non-disclosure were fear of the provider’s disapproval36,42,54–56,67,76–78,83–85,90,92,105,107,110–113, followed by 
the provider not asking37,42,54–57,59,67,76–78,83,84,90,98,110–113, the patient perceiving disclosure as unimpor-
tant42,54–57,59,67,76,78,79,84,85,90,92,98,105,107,110, belief the physician would not have relevant knowledge of CM36,42,54,56,67,76–
78,107,113, lack of time during consultation or forgetting36,42,54,56,57,76,78,92,105, belief that CM was safe and would not 
interfere with conventional treatment42,78,83,85,111, the patient not using CM regularly or at the time of consulting 
with the conventional provider54,78,83,85, and previous experiences of a negative response from conventional pro-
viders54,84,90,112. The most commonly cited reason for disclosure was that the provider asked about CM use56,111,112, 
followed by the patient expecting the provider to be supportive of their CM use112,113, believing disclosure was 
important for safety56,113, belief the provider would have relevant knowledge or advice about CM56, and belief that 
disclosing CM use may help other patients with the same condition56. Full details of reasons are shown in Table 5.
When participants were asked whether they thought disclosure was important, more than 67% agreed it 
was36,63,68,80,110. This percentage was highest (93%) among participants who were surveyed in CM clinics68, which 
was consistent with other studies reporting higher disclosure rates among users of practitioner-provided CM 
compared with self-administered CM50,51,81,89. Conversely, one study found lower disclosure rates among those 
using practitioner-provided CM, specifically where participants were consulting a CM practitioner and a medical 
provider for the same condition65.
Impact of provider response on decisions to disclose. In a qualitative analysis, Shelley et al. found 
patients’ perceptions of how their medical provider might respond to their CM use was an important factor in the 
decision of whether or not to disclose112. A perception of the medical provider as accepting and non-judgemental 
encouraged disclosure while fear of a negative response from their medical provider led to non-disclosure112. One 
paper reported 59% of participants wanted to discuss CM with their medical provider (despite only 49% having 
done so), and 37% of non-disclosers wished it were easier to have such discussions35. In another study, the per-
centage of participants who wanted to discuss CM with their provider represented a substantial majority at 82% 
(despite only 60% having done so)61.
When the actual response of the provider to disclosure of CM use was explored by researchers, negative 
or discouraging responses were reported by a minority of respondents representing less than 20% of disclos-
ers65,71,77,85,105, or were not reported at all111. However, in five papers positive or encouraging responses to dis-
closure of CM use by a medical doctor were reported by a substantial proportion of respondents representing 
32–91% of disclosers63,65,77,79,85,105. Neutral responses from medical providers were also common, reported by 
8–32% of disclosers in three studies77,85,111.
Discussion
This review and meta-analysis provides a detailed overview and update of CM use disclosure to medical provid-
ers. Regarding the update to the 2004 paper20 afforded by this review, a substantially larger volume of literature 
reporting on CM disclosure was identified in our search, suggesting an increase in researcher interest in this 
aspect of patient-provider communication. Our analysis reveals little discernible improvement to disclosure rates 
over the last thirteen years. Consistent with the findings of the previous review, we found reports of disclosure 
vary widely. However, our additional meta-analysis on selected papers shows approximately two in three CM 
users do not disclose their CM use to medical providers. In view of the potential risks associated with unmanaged 
concomitant use of conventional and complementary medicine11,14, the value of increasing this rate of disclosure 
is accentuated.
Furthermore, our narrative review identified three distinct yet interrelated findings relating to 
patient-practitioner communication. Firstly, disclosure of CM use to medical providers is influenced by the 
nature of providers’ communication style; secondly, perceived provider knowledge of CM use is a barrier to dis-
cussions of CM use in clinical consultation; and thirdly, such discussions and subsequent disclosure of CM use 
may be facilitated by direct inquiry about CM use by providers. We consider this in the context of contemporary 
person-centred health care models.
Communication style was a repeated factor affecting disclosure rates in this review; disclosure of CM use 
was found to be encouraged by patient perceptions of acceptance and non-judgement from medical pro-
viders112, and inhibited by patient fears or previous experiences of discouraging responses from provid-
ers36,42,54–56,67,76–78,83–85,90,92,105,107,110–113. In practice, negative responses from medical providers appear to represent 
a deviation from the more commonly positive or neutral responses noted by participants of the reviewed stud-
ies as well as others117,118. However, such fears and subsequent non-disclosure of CM use could potentially be 
addressed by medical providers through communication with patients about CM in a direct, supportive, 
non-judgemental manner to build trust and communicative success119.
The reviewed literature shows patient perceptions of medical providers as lacking relevant knowledge about 
CM is a notable reason for non-disclosure. While examination of provider attitudes was not within the scope 
of this review, three reviewed papers included an assessment of medical providers’ attitudes toward discussing 
CM and identified lack of CM knowledge as a cause of providers’ reluctance to initiate such discussions76,111,112. 
Providers’ own perceived lack of CM knowledge as an obstacle to patient-provider CM communication also 
reflects other research examining provider perspectives on CM120,121. While the inclusion of CM in medical 
school curricula does occur in some countries (e.g. the US122, Canada123, UK124, Germany125, and Switzerland126), 
and is of interest to medical students127,128, this level of CM learning appears insufficient to equip medical provid-
ers with the confidence to address patient CM queries120,121. Furthermore, the depth and scope of CM knowledge 
to be realistically encouraged amongst medical providers has been contested124,125 and may be best facilitated on a 
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First author Year Study design Setting Country Population
Sample (CM 
users) Disclosure rate CM type used Funding source
Herron35 2003 Cross-sectional survey
5 teaching 
physician offices United States
Adult patients of 
rural physician 
clinics
176 (110) 49% Various CM Not reported.
















Stevenson111 2003 Semi-structured interview
20 general 
practice clinics 





clinics, age ≥ 16
35 (28) NR Various CM
UK Department 
















Giveon36 2004 Cross-sectional survey
25 primary care 
clinics Israel
Patients of HMO 
clinics 723 (261) 55% Various CM Not reported.




























174 (82) 69% Various CM Mercy Foundation








age ≥ 18, residents 
of Eastern Turkey
714 (499) 15% Various CM Not reported.







Adults living in 
































Busse42 2005 Cross-sectional survey
Naturopathic 
college clinic Canada
Patients of clinic, 






Kim43 2005 Cross-sectional survey
4 Emergency 
departments, 









539 (199) 36% Various CM Not reported.





residents, age ≥ 18
468 (356) 26% Various CM Not reported.
Shahrokh44 2005 Cross-sectional survey
Congregate 






69 (35) 77% Herbs and nutrients Not reported.







and their children 
who used herbs in 
past 12 months
2,982 (2,982) 34% Medicinal herbs Not reported.
Brunoa94 2005 Cross-sectional survey
2002 NHIS Alt 




5,860 (NR) 43% Herbs Not reported.
Kennedya46 2005 Cross-sectional survey
2002 NHIS Alt 









Kennedya47 2008 Secondary analysis of data from Kennedy 2005 (above), describes characteristics of disclosers by ethnic sub-group 18–37%
Continued
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First author Year Study design Setting Country Population
Sample (CM 
users) Disclosure rate CM type used Funding source
Birdeea48 2008 Cross-sectional survey
2002 NHIS Alt 








Birdeea49 2009 Cross-sectional survey
2002 NHIS Alt 
Med Suppl. United States
Civilian adults, 
sub-population: 
t’ai chi, qigong 
users




















data set 2,003 (2,003) 66%
Faithb51 2013 Cross-sectional survey
2001 HCQS 




1,995 (1,995) 71% Various CM Not reported.
Wua,c52 2011 Cross-sectional survey








supplements Not reported.2007 NHIS Alt 
Med Suppl. 22,657 (3,982) 46%
Gardinera100 2007 Cross-sectional survey
2002 NHIS Alt 








Laditkac53 2012 Cross-sectional survey
2007 NHIS Alt 










Shimc89 2014 Cross-sectional survey
2007 NHIS Alt 




7,347 (7,347) 46% Various CM Not reported.
Jou54 2016 Cross-sectional survey
2012 NHIS Alt 
Med Suppl. United States
General 
population 
adults ≥ 18 
using both CM 
& primary care 
physician
7,493 (7,493) 59% Various CM University of Minnesota.








carer) of any age 
attending hospital 
500 (206) 34%
Various CM Not reported.
Royal Children’s 
Hospital Australia 503 (258) 37%
MacLennan104 2006 Cross-sectional survey
Health 
Omnibus 
Survey of South 
Australian 
households
Australia South Australian residents, age ≥ 15 3,015 (1,574) 47% Various CM Not reported.








wards, age ≥ 18
250 (106) 9% Herbal medicine Not reported.
Shah56 2006 Cross-sectional survey
Mail via market 
research co. United States
Adult Ohio 
residents age ≥ 18 210 (100) 11–44% Herbal Not reported.



























adults, age ≥ 65



















Patients aged ≥ 16 
who used herbal 
remedies
265 (265) 23% Herbal remedies Not reported.
Continued
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First author Year Study design Setting Country Population
Sample (CM 
users) Disclosure rate CM type used Funding source







the hospital as 
outpatients
114 (61) 47% Various CM No funding received.
Rivera33 2007 Cross-sectional survey
Households in 
border cities 
of El Paso & 
Cuidad Juarez














































age ≥ 18, sub-
population: older 
adults age ≥ 65
178 (NR) 60% Various CM Not reported.
AlBraik92 2008 Cross-sectional survey
Primary health 








for general health 
care





















adults ≥ 18, 
representative of 
local population
873 (484) 26% Herbal medicine Not reported.
Cizmesija61 2008 Cross-sectional survey






941 (301) 60% Various CM Not reported.









clinics, age ≥ 18
496 (246) 42% Various CM Not reported.






of) attending as 
outpatients and 
inpatients
185 (105) 40% Various CM Not reported.
Ozturk63 2008 Cross-sectional survey
Paediatric 
outpatient 







600 (339) 51% Various CM Not reported.










243 (69) 46% Various CM No funding received.









430 (196) 40% Herbal and non-herbal Not reported.
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First author Year Study design Setting Country Population
Sample (CM 
users) Disclosure rate CM type used Funding source
Shelley112 2009 Multistage qualitative
Low-income 
serving primary 
care clinics and 
community, 


















Delgoda99 2010 Cross-sectional survey 18 pharmacies Jamaica
Adults and 
parents/carers or 
children who were 
using prescription 
medicines





the West Indies, 
SuperPlus Food 
Stores






328 (89) 34% Various CM RCSI




residents, age ≥ 18 3,876 (1,518) 38% Herbs Not reported.




Australia Hospitalised adults, age ≥ 18 353 (319) 38–48%
Herbs and other 
CM Not reported




of) and parents, 
age ≥ 17
268 (193) 32% Various CM Not reported.




of) and parents, 
insured
599 (NR) 19%, 61%f Various CM No funding received.






305 (89) 25% Herbs Not reported.











Picking70 2011 Cross-sectional survey
Households in 3 
districts Jamaica
Adults from 
urban and rural 
districts






















Elolemy72 2012 Cross-sectional survey
Households 
within Riyadh 






518 (438) 51% Various CM No funding received.















































Zhang76 2012 Cross-sectional survey
Ambulatory 
family medicine 




clinics, age ≥ 18
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First author Year Study design Setting Country Population
Sample (CM 
users) Disclosure rate CM type used Funding source
Arcury113 2013 Ethnographic interview
Senior meal & 
housing sites United States
Community-
dwelling older 
adults, age ≥ 65
62 (39) 59% Various CM National Center for CAM




the GP office, 
age ≥ 18














of) attending GP, 
age ≥ 16



















survey 2,266 (NR) 52%








patients & healthy 



















care services, age 
18–89




























free medical care 
at remote area 
medical events, 
age ≥ 18
192 (94) 44% Various CM Not reported.
Shumer81 2014 Cross-sectional survey
3 Rural family 
medicine clinics Japan
Adults who visit 
rural Japanese 
family medicine 
clinics, age ≥ 20










for any reason, 
age ≥ 18
228 (187) 34% Various CM Not reported.









both CM & 
medication, 
age < 20 to > 60















7,674 (1,729) 52% Various CM Not reported.
Gardiner101 2015 Cross-sectional survey
Boston Medical 














324 (279) 12% Traditional CM of Ghana






in Africa and 
French Embassy 
in Ghana Grant 
Programme.
Naja85 2015 Cross-sectional survey
Face to face in 
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case by case basis taking into account the circumstances of both provider and patient involved. Ideally, regardless 
of the level of CM knowledge held, the medical provider should strive to facilitate overall coordination and con-
tinuity of care for patients covering all treatments and providers, including those of CM.
Our analyses suggest there may be a vital role for medical providers in facilitating patient preference by 
enquiring with patients about CM in order to help improve disclosure rates. Other studies show discussions in 
conventional medical settings about CM use are more commonly patient rather than provider initiated118,129, 
a pattern reflected in the findings of some papers in this review35,68,76. This pattern suggests provider initiation 
of such discussions may be an avenue for improving disclosure rates, which may be achieved by means such as 
standard inclusion of CM use inquiry in case-taking education for medical students, as is currently the case in 
Switzerland130. Indeed, examination of the impact on disclosure rates of specific questions related to dietary sup-
plements found medical providers’ questioning more than doubled the rate of supplement use disclosure131. This 
communicative success may be facilitated through employment of person-centred approaches to clinical care, 
which encompass patient involvement in shared decision-making, provider empathy and recognition of patients’ 
values119, encouraging a shared responsibility for communication and subsequent discussion of CM use.
While this review provides insight which could be integral to improving patient care during concomitant 
use of CM and conventional medicine, it also reveals the complexities of patient-practitioner communication in 
contemporary clinical settings. Further research into the nature of prevailing communication patterns, including 
differences in disclosure behaviours between populations of different demographics, is needed. As research into 
disclosure becomes more nuanced and data collection more consistent (e.g. through development and use of 
standardised instruments), future research could examine changes in patterns of and influences on disclosure. 
Additionally, research exploring the relationship between communication and treatment outcomes is warranted 
to provide a richer, deeper understanding of the impact of patient care dynamics. Such understanding could argu-
ably provide the scaffolding for robust, effective, efficient public health policy and practice guidelines.
Limitations of this review. The findings from our review need to be considered within the context of 
certain limitations. The varied nature and lack of a consistent international definition of CM lend a high degree 
of heterogeneity to the collection of studies appraised132. Likewise, while the wide variation in disclosure rates 
is likely to be partially due to confounding factors relating to differences among target populations (e.g. age, 
gender), settings (e.g. hospital, community clinics), geographical location (e.g. country/region), and sample 
sizes, the absence of a standard, validated tool for measuring disclosure also impacts the analysis and report-
ing on disclosure rates. The heterogeneity produced by these limitations reduced the number of papers suitable 
for meta-analysis and prevented a more robust, fixed-model meta-analysis on this topic, as well as prohibiting 
meta-analyses of CM categories other than biologically-based CM due to insufficient data. Additionally, iden-
tifying a comprehensive selection of studies to review was difficult due to disclosure frequently being reported 
as a secondary outcome and thus not being mentioned in the paper’s title, abstract or keywords. However, these 
limitations have been minimised where possible by following systematic review best practice, and while remain-
ing mindful of the limitations of our review, the importance of the findings presented here for contemporary 
healthcare practice and provision should not be underestimated.
First author Year Study design Setting Country Population
Sample (CM 











clinics, age ≥ 18
603 (477) 34–49% Dietary supplements
National Center 
for CAM. Office 
of Dietary 
Supplements.









Cramer91 2016 Cross-sectional survey
2012 NHIS Alt 




34,525 (4,422) 34% Yoga German Assn of Yoga Teachers.
Hsu87 2016 Cross-sectional survey
Public health 
centre United States




50 (35) 31% Chinese herbal Not reported.
Lauche90 2016 Cross-sectional survey
2012 NHIS Alt 
Med Suppl. United States
Civilian adult 
sub-population: 
t’ai chi, qigong 
users
34,525 (NR) 42% T’ai chi & Qigong Not reported.







203 (187) 36% Various CM Not reported.
Table 4. Study characteristics and details of disclosure. CM = complementary medicine; NR = Not reported; 
Disclosure rate = % of CM users. aStudies conducted different analyses on sub-populations from the same 2002 
NHIS data source. bStudies use same 2001 HCQS data, with slightly different sample size and results due to how 
data was handled. cStudies use same 2007 NHIS data, with slightly different sample size and results due to how 
data was handled. dRate is % of CM users who also saw a physician. eRate is % of CM users who were also taking 
conventional medications. fDisclosure of CM to physician by patients from conventional clinics (19.4%) vs CM 
(61.2%) clinics.
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Conclusion
The rate of disclosure regarding CM use to medical providers remains low and it appears that disclosure is still 
a major challenge facing health care providers. This review, alongside previous research, suggests that patient 
decision-making regarding disclosure and non-disclosure of CM use to a medical provider is impacted by 
the nature of patient-provider communication during consultation and perceptions of provider knowledge of 
CM. The initiation of conversations about CM with patients and provision of consultations characterised by 
person-centred, collaborative communication by medical providers may contribute towards increased disclo-

















































0 0.25 0.5 0.75
Prevalence of disclosure
Figure 2. Meta-analysis results: disclosure rates for biologically-based complementary medicine. Results 
of meta-analysis assessing rates of disclosure of biologically-based complementary medicine use to medical 
providers.
No. of 




Patient was afraid of physician’s response or thought physician will 
disapprove 20
36,42,54–56,67,76–78,83–85,90,92,105,107,110–113
Physician didn’t ask or wasn’t interested 19 37,42,54–57,59,67,76–78,83,84,90,98,110–113 54–57,77,84
Patient didn’t think it was important or necessary 18 42,54–57,59,67,76,78,79,84,85,90,92,98,105,107,110 59,67,76,78,79
Didn’t think physician had relevant knowledge/wasn’t their business 
to know 10
36,42,54,56,67,76–78,107,113 36
No time/physician too busy/didn’t think about it/forgot 9 36,42,54,56,57,76,78,92,105 42
Thought CM was safe/wouldn’t interfere with treatment 4 78,83,85,111 83
Was not using CM at the time/not using CM regularly/not attending 
a physician at the time 4
54,78,83,85 85
Previous negative response or bad experience with disclosing 4 54,84,90,112
Patient had enough knowledge about CM 1 42
Wanted to compare advice between conventional and CM 
practitioners 1
113
Desire to protect cultural knowledge about CM 1 113




Physician asked 3 56,111,112
Patient believed physician would be supportive 2 112,113
Patient believed it was important for safety reasons 2 56,113 56
Patient believed physician would have relevant knowledge or advice 
about CM 1
56
To help someone else with the same condition 1 56
Table 5. Reasons for non-disclosure and disclosure. aStudies in which the corresponding reason was the reason 
most commonly reported by participants.
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conventional medical care. This is a topic which should be treated with gravity; it is central to wider patient man-
agement and care in contemporary clinical settings, particularly for primary care providers acting as gatekeeper 
in their patients’ care.
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